Royal Fund Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-83	Closed	-$6K	–	642
2017 Q4	$6K	Buy	+83	New	+$6K	﹤0.01%	456